Cigna (CI)

NYSE Health Care Health Care Services S&P 500
$293.59
-7.89 (-2.62%)
Close of Nov 06, 2026 · end-of-day data
Source: Cigna's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$39.84B$41.81B$48.65B$153.57B$160.40B$174.07B$180.52B$195.26B$247.12B$274.90B
Cost of revenue$2.47B$2.46B$4.79B$97.67B$103.48B$117.55B$124.83B$133.80B$182.51B$214.99B
Gross profit$37.37B$39.35B$43.86B$55.90B$56.92B$56.52B$55.68B$61.46B$64.61B$59.91B
Selling, general & admin$9.79B$10.03B$11.93B$14.05B$14.07B$13.01B$13.17B$14.82B$14.84B$14.62B
Operating income$3.09B$3.94B$4.16B$8.08B$8.15B$7.94B$8.45B$8.54B$9.42B$9.20B
Interest expense$251.00M$243.00M$507.00M$1.60B$1.40B$1.30B$1.30B$1.40B$1.50B$1.40B
Pre-tax income$2.98B$3.61B$3.58B$6.57B$10.87B$6.79B$8.40B$5.51B$5.27B$7.78B
Income tax$1.14B$1.37B$935.00M$1.45B$2.38B$1.37B$1.61B$141.00M$1.49B$1.49B
Net income$1.87B$2.24B$2.64B$5.10B$8.46B$5.37B$6.70B$5.16B$3.43B$5.96B
EBITDA$3.70B$4.51B$4.86B$11.73B$10.96B$10.86B$11.39B$11.57B$12.19B$11.97B
EPS (basic)$7.31$8.92$10.69$13.58$23.17$15.89$21.66$17.57$12.25$22.33
EPS (diluted)$7.19$8.77$10.54$13.44$22.96$15.75$21.41$17.39$12.12$22.18
Diluted shares259.65M255.07M250.22M379.82M368.39M340.97M313.06M296.88M283.22M268.56M
Gross margin93.8%94.1%90.1%36.4%35.5%32.5%30.8%31.5%26.1%21.8%
Operating margin7.8%9.4%8.6%5.3%5.1%4.6%4.7%4.4%3.8%3.3%
Net margin4.7%5.4%5.4%3.3%5.3%3.1%3.7%2.6%1.4%2.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$3.19B$2.97B$3.85B$4.62B$10.18B$5.08B$5.92B$7.82B$7.55B$7.68B
Short-term investments—$2.14B$2.04B$937.00M$1.33B$920.00M$905.00M$925.00M$665.00M$1.06B
Receivables—$3.15B$10.47B$10.72B$12.19B$15.07B$17.22B$17.72B$24.23B$28.77B
Inventory—$228.00M$2.82B$2.66B$3.17B$3.72B$4.78B$5.64B$6.69B$7.34B
Total current assets—$9.31B$20.43B$29.84B$27.80B$36.13B$30.12B$37.35B$48.87B$47.81B
Goodwill$5.98B$6.16B$44.51B$44.60B$44.65B$45.81B$45.81B$44.26B$44.37B$44.92B
Total assets—$61.76B$153.23B$155.77B$155.45B$154.89B$143.88B$152.76B$155.88B$157.92B
Total current liabilities—$11.01B$31.89B$40.14B$36.02B$43.57B$41.23B$48.72B$57.98B$56.34B
Short-term debt—$240.00M$2.96B$5.51B$3.37B$2.54B$2.99B$2.77B$3.04B$592.00M
Long-term debt—$5.20B$39.52B$31.89B$29.55B$31.12B$28.10B$28.16B$28.94B$30.87B
Total debt—$5.44B$42.48B$37.41B$32.92B$33.67B$31.09B$30.93B$31.97B$31.46B
Total liabilities—$48.00B$112.15B$110.39B$105.06B$107.70B$99.13B$106.41B$114.64B$116.05B
Shareholders' equity$13.70B$13.71B$41.03B$45.34B$50.32B$47.11B$44.67B$46.22B$41.03B$41.71B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$4.03B$4.09B$3.77B$9.48B$10.35B$7.19B$8.66B$11.81B$10.36B$9.60B
Capital expenditures$461.00M$471.00M$528.00M$1.05B——————
Free cash flow$3.56B$3.62B$3.24B$8.44B$10.35B$7.19B$8.66B$11.81B$10.36B$9.60B
Investing cash flow-$2.57B-$1.70B-$26.38B-$734.00M$2.98B-$3.61B$3.10B-$5.17B-$2.10B-$4.41B
Financing cash flow-$225.00M-$2.65B$23.52B-$7.19B-$8.53B-$8.21B-$11.24B-$4.29B-$7.65B-$6.42B
Dividends paid———$15.00M$15.00M$1.34B$1.38B$1.45B$1.57B$1.61B
Share buybacks$139.00M$2.73B$342.00M$1.99B$4.04B$7.74B$7.61B$2.28B$7.03B$3.62B
Stock-based compensation$128.00M$178.00M$180.00M$299.00M$289.00M$268.00M$264.00M$286.00M$308.00M$291.00M
Depreciation & amortization$610.00M$566.00M$695.00M$3.65B$2.80B$2.92B$2.94B$3.04B$2.77B$2.77B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.